EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors

Phil M M Hochban, Lukas Heyder, Andreas Heine, Wibke E Diederich

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202400094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Phil M M Hochban und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Pharmazeutische Chemie, Zentrum für Tumor und Immunbiologie, Philipps-Universität Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Proto-Oncogene Proteins c-pim-1, Stilbenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Helmholtz-Zentrum für Materialien und Energie, Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, we have developed novel Pim‐1 kinase inhibitors starting from a dihydrobenzofuran core structure using a computational approach. Here, we report the design and synthesis of stilbene‐based Pim‐1 kinase inhibitors obtained by formal elimination of the dihydrofuran ring. These inhibitors of the first design cycle, which were obtained as inseparable cis / trans mixtures, showed affinities in the low single‐digit micromolar range. To be able to further optimize these compounds in a structure‐based fashion, we determined the X‐ray structures of the protein‐ligand‐complexes. Surprisingly, only the cis ‐isomer binds upon crystallization of the cis / trans ‐mixture of the ligands with Pim‐1 kinase and the substrate PIMTIDE, the binding mode being largely consistent with that predicted by docking. After crystallization of the exclusively trans ‐configured derivatives, a markedly different binding mode for the inhibitor and a concomitant rearrangement of the glycine‐rich loop is observed, resulting in the ligand being deeply buried in the binding pocket.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase InhibitorsProto-Oncogene Proteins c-pim-1StilbenesHumansBinding SitesCrystallography, X-RayDrug DesignLigandsModels, MolecularMolecular Docking SimulationMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

Pim‐1 kinasedrug designprotein crystallographystilbene‐based inhibitors

Substanzen

LigandsProtein Kinase InhibitorsProto-Oncogene Proteins c-pim-1StilbenesPIM1 protein, human

Autor:innen und Institutionen

  • Institut für Pharmazeutische Chemie, Zentrum für Tumor und Immunbiologie, Philipps-Universität Marburg, Marburg, Germany.
  • Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.

Förderung

  • Helmholtz-Zentrum für Materialien und Energie, Berlin

Zitieren

APA

Hochban, P. M. M., Heyder, L., Heine, A., & Diederich, W. E. (2024). What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400094

Vancouver

Hochban PMM, Heyder L, Heine A, Diederich WE. What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400094

BibTeX
@article{Hochban2024,
  author = {Hochban, Phil M M and Heyder, Lukas and Heine, Andreas and Diederich, Wibke E},
  title = {What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202400094}
}
Kostenlos starten →